Individualizing gentamicin dosage regimens in burn patients with gram‐negative septicemia: A cost‐benefit analysis

J. Lyle Bootman, Albert I. Wertheimer, Darwin Zaske, Clayton Rowland

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Individualizing gentamicin dosage regimens in burn patients with gram‐negative septicemia: A cost‐benefit analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds